Genetic risk identifies multiple myeloma patients who do not benefit from autologous stem cell transplantation (Q81093853)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113669%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Genetic risk identifies multiple myeloma patients who do not benefit from autologous stem cell transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113669%20AND%20SRC:MED&resulttype=core&format=json

stem cell transplantation

5 January 2020

main subject

1 reference

1 reference

Chang H

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113669%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Qi XY

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113669%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Samiee S

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113669%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Yi QL

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113669%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Chen C

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113669%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Trudel S

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113669%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Mikhael J

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113669%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Reece D

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113669%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Stewart AK

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113669%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 November 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113669%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113669%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113669%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113669%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

793-796

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113669%20AND%20SRC:MED&resulttype=core&format=json

High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705131

7 January 2021

Chromosome translocations in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705131

7 January 2021

Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705131

7 January 2021

The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705131

7 January 2021

p53 gene deletion detected by fluorescence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705131

7 January 2021

Detection of chromosome 13q deletions and IgH translocations in patients with multiple myeloma by FISH: comparison with karyotype analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705131

7 January 2021

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705131

7 January 2021

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705131

7 January 2021

Treatment of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705131

7 January 2021

Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705131

7 January 2021

The t(4;14)(p16.3;q32) is strongly associated with chromosome 13 abnormalities in both multiple myeloma and monoclonal gammopathy of undetermined significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705131

7 January 2021

Clinical and biologic implications of recurrent genomic aberrations in myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705131

7 January 2021

Predictive role of interphase cytogenetics for survival of patients with multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705131

7 January 2021